Interestingly, our transcriptomic analysis revealed that TAP1 expression is reduced after TAP2 silencing in lung cancer cells, and TAP2 is also reduced after TAP1 downregulation, supporting interdependency in the expression of these proteins. The gene discussed is TAP2; the disease is lung carcinoma.